珠海都市网
您当前的位置 :首页 > 文传商讯 > 正文
Medisca and EUROAPI Form Strategic Partnership to Strengthen API Access for Pharmaceutical Compounding
2026年10月12日 18:26:33来源:作者:
【摘要】 This partnership brings together EUROAPI鈥檚 European pharmaceutical manufacturing capabilities and Medisca鈥檚 compounding expertise to expand access, strengthen its API portfolio and advance collaboration in peptides.MONTREAL--(BUSINESS W

This partnership brings together EUROAPI鈥檚 European pharmaceutical manufacturing capabilities and Medisca鈥檚 compounding expertise to expand access, strengthen its API portfolio and advance collaboration in peptides.

MONTREAL--(BUSINESS WIRE)--Medisca and EUROAPI have formed a strategic partnership focused on expanding API access for pharmaceutical compounding, creating differentiated access in North America and establishing a broader framework for international growth and peptide collaboration.

For more than three decades, Medisca has built its business around the evolving needs of pharmaceutical compounders. That starts with the products it chooses to bring to market but extends much further to the manufacturers behind them, the documentation and technical information supporting them, and the quality systems that carry those products through to the customer.

The partnership with EUROAPI advances that approach. Under the new strategic partnership, Medisca becomes EUROAPI’s first strategic distribution partner focused on bringing its European-manufactured APIs to the North American compounding market. The collaboration includes exclusive supply arrangements for selected APIs and creates a framework to expand the offering over time, enter additional markets and advance new areas of pharmaceutical innovation.

For customers, the value goes beyond adding more APIs to a catalogue. The partnership creates a stronger connection between manufacturing expertise and the needs of the compounding market, supported by technical information, product documentation and Medisca’s direct customer insight. This allows Medisca to respond more closely to what compounders need today and continue adapting its offering as those needs change.

“This partnership marks an important milestone in the growth of Medisca,” said Peng Li, Chief Business Officer at Medisca. “EUROAPI brings deep manufacturing and technical expertise, with a strong focus on quality, green chemistry and sustainability. These strengths align with the evolving needs of the compounding market as personalized medicine continues to grow across telehealth, wellness and new areas of patient care. Together, we are expanding API access, building new opportunities across markets and advancing collaboration in peptides. We are proud to partner with EUROAPI and confident in the long-term potential of what we can build together.”

At the center of the partnership is a shared ambition to bring pharmaceutical manufacturing expertise, technical rigor and a strong quality foundation closer to the evolving needs of the compounding industry. Medisca’s approach begins at the source, with the manufacturer, the specifications and technical documentation behind an API and continues through the quality systems and controls that support it through to the customer. Through the partnership, EUROAPI will provide available technical and regulatory information relating to the APIs, strengthening the connection between manufacturing expertise and Medisca’s quality infrastructure. EUROAPI’s focus on green chemistry, and sustainability further supports Medisca’s commitment to responsible sourcing and broader social impact.

The relationship is also designed to grow. Medisca and EUROAPI intend to collaborate on customer initiatives, training and commercial activities, while adding new APIs over time and evaluating opportunities across additional markets.

Advancing collaboration in peptides

Peptides are an important area of strategic collaboration for Medisca and EUROAPI. As Medisca continues to expand its global peptide strategy for pharmaceutical compounding and personalized medicine, the companies intend to explore opportunities that combine Medisca’s market expertise with EUROAPI’s capabilities in complex API development and manufacturing. The collaboration creates a foundation to advance their work in peptides as the market continues to evolve.

“Medisca’s depth of expertise in pharmaceutical compounding and its close understanding of the market make it a strong strategic partner for EUROAPI,” said Frederic Robert, Chief Commercial Officer at EUROAPI. “This relationship creates new opportunities to broaden access to our APIs, expand our reach in the compounding market and develop our collaboration in areas such as peptides. We see significant potential to grow together over the long term.”

For Medisca, the partnership marks another step in its broader strategy to strengthen its API offering through direct relationships with pharmaceutical manufacturers, expand differentiated access for customers and build for the next generation of personalized medicine.

To explore EUROAPI-manufactured APIs available through Medisca, visit www.medisca.com

About Medisca
Founded in 1989, Medisca is a leader in personalized medicine and pharmaceutical supply chain solutions, with a vast portfolio of over 2,000 products complemented by a library of 10,000+ proprietary and customized medication formulas, expertise and services in pharmaceutical compounding, continuing healthcare education, and analytical testing. Providing finely-tuned solutions to diverse wellness sectors in numerous markets globally, Medisca is bridging the gaps in healthcare and empowering personalized wellness for all. For more information, visit www.medisca.com and follow us on LinkedIn, Facebook, and YouTube.

About EUROAPI
EUROAPI is focused on reinventing active pharmaceutical ingredients to sustainably meet customers’ and patients’ needs around the world. We are a leading player with approximately 200 products in our portfolio, offering a large span of technologies while also developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities.

With strong R&D capabilities and five manufacturing sites located in Europe, EUROAPI provides its clients with high-quality API solutions in more than 80 countries. Our 3000+ people are committed to building together the future of public health by advancing and securing access to essential active ingredients, at the core of the healthcare value chain. EUROAPI is listed on Euronext Paris: EAPI. Find out more at www.euroapi.com and follow us on LinkedIn.

 

责任编辑: admin

看新闻,关注新闻

本网网友:圈套  Easuysug▍
评论:等我死了,我就让我儿子给我放潇洒走一回

搜狐网友:暖心 Vicious▽
评论:我来到我们来过的小路,捡起我们可耻的幸福。

猫扑网友:解脱的诠释
评论:什么是兄弟?兄弟就是50年后你老了躺在床上,我问你喝水不?你摇头。吃水果不?你还是摇头。我再问:给你找个妞?你睁大眼睛,眼里闪着泪花。兄弟,扶我起来试试。。。

其它网友:潇洒 小姐 Seve°
评论:男女中之所以有纯洁的友谊,是因为女生长得不够漂亮

腾讯网友:俄徹底心灰
评论:男人有了烟,有了啤酒,也就有了故事;女人有了钱,有了姿色,也就有了悲剧

淘宝网友:惜一丝清冷
评论:在身材这个问题上,我是坚决不会承认自己是一个粗人的。

百度网友:Chafferer  迷心
评论:钱多钱少,够吃就好。人丑人美,顺眼就好。人老人少,健康就好。家穷家富,和气就好。

网易网友:ゆ.咬破红唇
评论:我其实是个天使,之所以留在人间,是因为体重的关系

天涯网友:快樂始于釋懷
评论:人生如同故事,重要的并不是有多长,而是在有多好。

凤凰网友:听ヽ天甾哭泣
评论:因最近频繁地震,通往爱情的路已断裂,请您绕道而行

相关阅读
分享到:
版权和免责申明

珠海都市网所有文字、图片、视频、音频等资料均来自互联网,不代表本站赞同其观点,本站亦不为其版权负责。相关作品的原创性、文中陈述文字以及内容数据庞杂本站无法一一核实,如果您发现本网站上有侵犯您的合法权益的内容,请联系我们,本网站将立即予以删除!